1. Home
  2. |Insights
  3. |Understanding the False Claims Act Risks Facing U.S. Importers

Understanding the False Claims Act Risks Facing U.S. Importers

Webinar | 06.11.19, 8:00 AM EDT - 9:00 AM EDT

In recent years, there has been a steady rise in the number of lawsuits brought under the False Claims Act (FCA) alleging that importers have concealed obligations to pay duties to U.S. Customs and Border Protection. The increase in the number of qui tam suits filed by whistleblowers, combined with the current administration’s protectionist policies, suggests that U.S. importers could face increased FCA risks for years to come. 


This webinar will provide an overview of the FCA and the “reverse false claim” theory of liability that applies in duty evasion cases where an importer is alleged to have made false statements about tariff classification, country of origin, or the value of goods. The presenters will analyze recent enforcement trends, discuss considerations for responding to a government FCA investigation, and share practical steps that importers can take to mitigate risks.


For more information, please visit these areas: International Trade, False Claims Act Defense, Customs Fraud and the False Claims Act

Contact

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.